/Investor DB

Alta Life Sciences — 2020 Investments

4 investments dated 2020 · listed companies and verified rows first · show all

Accureaccure.healthSeries A · May 2020 · $8M

Accure Health is a company focused on developing treatments to improve the lives of patients and their relatives affected by central nervous system (CNS) diseases.

BiotechHealthtech

Laurent Nguyen(CEO)inPablo Villoslada(CSO)inRossella Medori(CMO)inPaul Bikard(CFO)in

Co-investorsAliath BioventuresAsabys PartnersKinled Holding

Deepulldeepull.cominSeries A · Jul 2020 · $4M

Deepull develops a multiplex PCR diagnostic system to rapidly identify sepsis-causing pathogens and antibiotic resistance markers directly from blood samples in approximately one hour, targeting hospitals and clinical laboratories.

Medical Devices

Co-investorsAsabys PartnersColumbus Venture Partners

Onaona.comin𝕏Jun 2020

Ona provides cloud-based agent infrastructure that runs developer tasks in isolated environments while laptops are closed, automating workflow execution through events, schedules, and pull requests.

AI & Machine LearningCloud ComputingDeveloper Tools

Co-investorsBright Pixel CapitalCrane Venture PartnersPebblebedPreston-Werner VenturesVertex VenturesAsabys Partners+5 more

Ona Therapeuticsona-therapeutics.comin𝕏Series A · Jun 2020 · $34M

Ona Therapeutics develops therapeutic antibodies targeting lipid metabolism to treat advanced and metastatic cancers, including liposarcoma.

BiotechHealthtechMedical Devices

Co-investorsAsabys PartnersFund+KorysMérieux Equity PartnersYsios CapitalBpifrance+2 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.